Leading healthcare IT analyst firm KLAS today released its 2020 Best in KLAS report. We are thrilled to announce that Bluesight for Controlled Substances received the honor of Category Leader in Drug Diversion Monitoring Solutions, earning a rating of 93.9 out of 100! The annual Best in KLAS report analyzes data from customers to provide accurate perspective on the products … Read More
KLAS report ranks Kit Check as the top performer with 93.9 rating for consistently delivering on product support, customer loyalty and quality of operations. WASHINGTON (January 31, 2020) — Kit Check™, the leader in automated and intelligent medication management solutions, today announced that its Bluesight™ for Controlled Substances diversion detection software has been named the Category Leader in Drug Diversion … Read More
The nation is in the grip of a tragic opioid crisis, and drugs that are meant for hospital patients are finding their way into other hands. Controlled substance diversion in hospitals is one culprit that is receiving increasing scrutiny. Quartz recently took a look at ways that hospitals can combat diversion among providers, including the role that technology can play. … Read More
Leading healthcare IT analyst firm KLAS today published its inaugural drug diversion monitoring solution report. We are thrilled to announce that Bluesight for Controlled Substances received top marks, earning a rating of 93.2* out of 100! KLAS’s “Drug Diversion Monitoring 2019, An Early Look at Emerging Vs. Established Technology” highlights hospitals and health systems’ need for drug diversion monitoring technology, … Read More
Yesterday, Kit Check announced the launch of a new feature for Bluesight for Controlled Substances, the Individual Risk Identification Score (IRIS). Venture Beat covered the announcement as IRIS uses artificial intelligence to predict which employees pose the highest risk for controlled substance theft. Kit Check CEO Kevin MacDonald commented in the article, “The technology calculates how unusual one’s behavior is … Read More
In the day-to-day battle against drug diversion, most solutions look at the data to find statistical outliers. Often the focus is on clinicians who may be logging more transactions than their peers, or on medications that are administered in unusual amounts or that go missing. We can call this the “Who” and the “What.” But we really have to look … Read More
Two weeks ago I had the pleasure of attending the International Health Facility Diversion Association (IHFDA) Conference in St. Louis. This 2nd annual gathering brought together practitioners, vendors and experts to share best practices around preventing, detecting and responding to diversion in hospitals. For those of you who weren’t able to make the event, here are three themes that resonated throughout the conference’s presentations and discussions.